Veterinary Therapeutics Market Research Report by Players Analysis (Boehringer Ingelheim Vetmedica, Bayer Animal Health, Inc., Dechra Animal Health, Ceva Sante Animale, Elanco Animal Health)

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and growing number of acute and chronic animal and zoonotic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Get a Sample Copy of Reoprt - http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14048

The global veterinary therapeutics market is plagued by concerns such as the need for substantial investments on research and development projects but the comparatively lower returns, decline in new chemical entities (NCE) approvals owing to stringent regulatory requirements, and an aging product portfolio. The factor of fewer NCE approvals in the past few years, has, especially, left vendors with less growth through lifecycle extension strategies. Stringent government regulatory and approval policies in some of the key regional markets could also be a major restraint for the market. For instance, the U.S. Animal and Plant Health Inspection Service revised regulations on product labels in July 2015. Prior to the implementation of these regulations, brands could claim any of four levels of efficacy, but now, only a single claim may be used.The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global veterinary therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global veterinary therapeutics market.

Based on product type, the global veterinary therapeutics market has been segmented into drugs (anti-infectives, anti-inflammatory, parasiticides, and others), vaccines (inactivated vaccines, live attenuated vaccines, recombinant vaccines, and others), and feed additives (amino acids, antibiotics, and others). The market has been further studied from the point of view of major animal types. Based on animal type, the market has been categorized into companion animals and livestock animals. On the basis of route of administration, the market has been segmented into oral, parenteral, and topical. Based on distribution channel, the market has been segmented into veterinary hospitals, veterinary clinics, pharmacies & drug stores, and others.

Geographically, the global veterinary therapeutics market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Australia, South Africa, Brazil, and Mexico. The report also profiles major players in the veterinary therapeutics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Dechra Animal Health, Elanco Animal Health, Merck Animal Health, Merial Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis, Inc.

Browse Report with Complete TOC - http://www.transparencymarketresearch.com/veterinary-therapeutics-market.html

Key Points from Table of Content

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Demand for High Quality Proteins
5.2.2. Growth in spend on companion animals globally
5.2.3. Increased medical and surgical capabilities for companion animals
5.2.4. Greater emphasis on prevention and wellness by veterinarians and owners
5.2.5. Increase in ownership of companion animals
5.2.6. Evolution of new products combating emergence of new diseases in animals
5.2.7. Development of vaccines and other pharma products to cope up with zoonotic disease concerns
5.3. Restraints
5.3.1. Low R&D returns and aging product portfolio
5.3.2. Stringent regulatory framework
5.3.3. Rising concern about the use of antibiotics and growth promoters in food animals
5.3.4. Prevalence of counterfeit medicines
5.4. Global Veterinary Therapeutics Market : Opportunity Analysis
5.5. Opportunities
5.5.1. Biologics and specialty care offer potential opportunities for players to invest in
5.5.2. Growing awareness and affordability of therapeutics for pets and livestock offer significant opportunity to new entrants
5.6. Key Trends
5.7. Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
5.8. Porter's Analysis
5.9. Veterinary Therapeutics Market Outlook

Chapter 6. Veterinary Therapeutics Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. Global Veterinary Therapeutics Market Value Share Analysis, by Product Type
6.4. Veterinary Therapeutics Market Analysis, by Product Type
6.4.1. Drugs
6.4.2. Vaccines
6.4.3. Medicated Feed Additives
6.5. Global Veterinary Drugs Market Analysis, by Drugs Type
6.5.1. Anti-infective
6.5.2. Anti-inflammatory
6.5.3. Parasiticides
6.5.4. Others
6.6. Global Veterinary Vaccines Market Analysis, by Vaccines Type
6.6.1. Inactivated Vaccines
6.6.2. Live Attenuated Vaccines
6.6.3. Recombinant Vaccines
6.6.4. Others
6.7. Global Veterinary Medicated Feed Additives Market Analysis, by Medicated Feed Additives Type
6.7.1. Antibiotics
6.7.2. Amino Acids
6.7.3. Others
6.8. Market Attractiveness Analysis, by Product Type
6.9. Key Trends

Chapter 7. Veterinary Therapeutics Market Analysis, by Animal Type
7.1. Key Findings
7.2. Introduction
7.3. Global Veterinary Therapeutics Market Value Share Analysis, by Animal Type
7.4. Veterinary Therapeutics Market Analysis, by Animal Type
7.4.1. Companion
7.4.2. Livestock
7.5. Market Attractiveness Analysis, by Animal Type
7.6. Key Trends

Chapter 8. Veterinary Therapeutics Market Analysis, by Route of Administration
8.1. Key Findings
8.2. Introduction
8.3. Global Veterinary Therapeutics Market Value Share Analysis, by Route of Administration
8.4. Veterinary Therapeutics Market Analysis, by Route of Administration
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Topical
8.5. Market Attractiveness Analysis, by Route of Administration
8.6. Key Trends

Get Year End Discounts - http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=14048

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.